Search Results for "Erwinia Asparaginase Availability"
Original Source: L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.
Asparaginases are a cornerstone of treatment protocols for acute lymphoblastic leukemia (ALL) and are used for remission induction and intensification treatment in all pediatric regimens and in the majority of adult treatment protocols. Extensive clinical data have shown that intensive asparaginase treatment improves clinical outcomes in childhood ALL. Three asparaginase preparations are available: the native asparaginase derived from Escherichia coli (E. coli asparaginase), a pegylated form of this enzyme...
Matching Channels
Nerve growth factor (NGF) is the prototypical member of the family of neurotrophin growth factors that are involved in the growth and survival of nervous tissue. NGF and its receptors, the tyrosine-...
Matching News
AIBioTech announces implementation of L-asparaginase activity assay for pediatric ALL
AIBioTech is pleased to announce implementation of a new laboratory derived test to measure L-asparaginase levels in patients being treated with any of the current asparaginase drugs including: Oncasp...
DUBLIN, Dec. 10, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that data from the largest safety trial to date of patients treated with Erwinaze® (asparag...
DUBLIN, Dec. 3, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled and dosed in a clinical trial of Erwinaze® (asparaginase Erwi...
L-asparaginase regulatory update
[Recordati]’s [Orphan Europe] gets {Graspa} rights from [Erytech]
[Orphan Europe], the rare disease division of [Recordati Industria Chimica & Farmaceutica SPA], has licensed European commercialization rights to the leukemia candidate {Graspa} (L-asparaginase) from...
AIBioTech™ is pleased to announce implementation of a new laboratory derived test to measure L-asparaginase levels in patients being treated with any of the current asparaginase...
Jazz Pharmaceuticals to Webcast Presentation at J.P. Morgan Healthcare Conference
DUBLIN, Jan. 2, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will webcast its presentation at the 31st Annual J.P. Morgan Healthcare Conference in...
Matching PubMed Articles
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.
Asparaginases are a cornerstone of treatment protocols for acute lymphoblastic leukemia (ALL) and are used for remission induction and intensification treatment in all pediatric regimens and in the ma...
In brief: asparaginase erwinia chrysanthemi (Erwinaze) for ALL.
Severe hyperlipidaemia with asparaginase therapy is rare. We report six cases, four of which developed significant problems with severe hyperlipidaemia during induction therapy for ALL and lymphoblast...
A 30-year-old manufacturing process for the biologic product L: -asparaginase from the plant pathogen Erwinia chrysanthemi was rigorously qualified and validated, with a high level of agreement betwee...
Asparaginase-associated pancreatitis in children.
l-asparaginase has been an element in the treatment for acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma since the late 1960s and remains an essential component of their combination chemot...
